Olanzapine Prophylaxis for Opioid-Induced Nausea and Vomiting: A Single-Arm Exploratory Study
{{output}}
Introduction: Opioid-induced nausea and vomiting (OINV) affects 10-45.3% of patients during opioid initiation or dose escalation. Although antiemetics are commonly administered when symptoms occur, their efficacy and safety for p... ...